Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Excelra, headquartered in Hyderabad, India, has announced its collaboration with H M Pharma Consultancy (HMPC), a life s...
Singapore: Boehringer Ingelheim Biopharmaceuticals has installed a fast track process transfer to commercial scale. Comp...
Singapore: US Food and Drug Administration (FDA) has approved Merck's RAGWITEK Tablet indicated as immunotherapy for the...
Singapore: Australian drug development company Agenix has appointed international biomedical business development expert...
Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko...
Singapore: Genentech, a member of the Roche Group, has achieved primary endpoint of a significant improvement in HER2-po...
Singapore: Prostate cancer is becoming increasingly common due to globally growing numbers of elderly men, and scientist...
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...
Singapore: A former employee of the Japanese drug maker Novartis, was arrested with allegations of data manipulation. So...
Eisai's UK subsidiary, Eisai Europe, has received a positive opinion from the European Medicines Agency's Committee for ...
Singapore: Takeda Pharmaceutical and H. Lundbeck A/S have submitted a new drug application (NDA) to the US Food and Drug...
Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a po...
Singapore: The US FDA has approved GSK and Pfizer-owned HIV dedicated firm, ViiV Healthcare's, Tivicay (dolutegravir) 50...
Singapore: FibroGen and Japanese company Astellas Pharma have initiated the first clinical study in the phase III clinic...
Singapore: Antisense Therapeutics, an Australian publicly listed biopharmaceutical drug discovery and development compan...
Singapore: US FDA has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin table...
Singapore: Eli Lilly and Company has outlined its strategies to face patent cliff expected in 2014. In a statement to in...
